Clinical Trials Logo

Clinical Trial Summary

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.


Clinical Trial Description

This is a prospective, multi-center, open-label, non-randomized bridging study to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to benign prostatic hyperplasia (BPH). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06236802
Study type Interventional
Source ProVerum Medical
Contact Diane Gargus
Phone 1-720-472-1504
Email diane@proverummedical.com
Status Recruiting
Phase N/A
Start date March 6, 2024
Completion date June 1, 2029